November 2nd, 2026FDA grants accelerated approval to DNA immunotherapy for adult recurrent respiratory papillomatosisThe FDA granted accelerated approval to Voceryq to reduce papilloma excision surgeries in adults with recurrent respiratory papillomatosis.Read more
November 16th, 2026Kristin MacGregor, PhD, on identifying perinatal depressionKristin Macgregor, PhD, on why perinatal depression goes unspoken and how screening and integrated behavioral health can close the care gap.Read more
November 16th, 2026US loses measles elimination status; ACOG releases statement"The loss of... measles elimination status represents a significant public health setback," said ACOG President Camille A. Clare, MD.Read more
November 16th, 2026Weekly review: Testosterone’s history, Peri-SS symptom scale, and moreGet caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.Read more
November 11th, 2026Adverse pregnancy outcomes tied to postpartum contraceptive choicesPatients with 3 or more adverse pregnancy outcomes had lower odds of postpartum contraceptive use in a PRAMS analysis of 222,412 individuals.Read more
November 11th, 2026What biomarker-guided preeclampsia care could look like Risk factors cast a wide net in preeclampsia prediction, but biomarkers could add precision, according to Dallas Reed, MD.Read more
November 6th, 2026Q&A: Kanchi Chadha, MD, FACOG, MSCP, on FDA boxed warning removalsKanchi Chadha, MD, FACOG, MSCP, supports reconsidering MHT boxed warnings but says the FDA cited no study behind the change.Read more
November 6th, 2026Maternal RSVpreF vaccine tied to fewer infant RSV hospitalizationsReal-world data show maternal RSVpreF vaccination was 82% effective against infant RSV LRTI hospitalization through 3 months.Read more